Clinical trials
Phase 3 Thrombocythemia, Essential trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| CTI BioPharma | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| PharmaEssentia | 2 |
| Case Comprehensive Cancer Center | 1 |
| INSYS Therapeutics Inc | 1 |
| Incyte Corporation | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Ronald Hoffman | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 17 |
| Polycythemia Vera | 12 |
| Primary Myelofibrosis | 11 |
| Myeloproliferative Disorders | 10 |
| Blast Crisis | 8 |
| Burkitt Lymphoma | 8 |
| Hodgkin Disease | 8 |
| Immunoblastic Lymphadenopathy | 8 |
| Immunoglobulin Light-chain Amyloidosis | 8 |
| Leukemia, Hairy Cell | 8 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.